1US FDA.FDA approve Olysio for the treatment of chronic hepatitis C in combination antiviral treatment [EB/OL].[2013-11-22].http://www.fda.gov/forconsumers/byau-dience/forpatientadvocates/ucm377234.htm.
2KENNETH A S,BERNARD R,KARL M N,et al.Macrocyclic inhibitors of hepatitis C virus:US,8153800[P].2012-04-10.
3FRIED M W,BUTI M,DORE G J,et al.Once-daily simepre-vir(TMC435)with pegylated interferon and ribavirin in treat-ment-nai've genotype 1 hepatitis C:The randomized PILLAR study [J].Hepatology,2013,58(6):1918-1929.
